Modalis Therapeutics Corporation
Latest round
- Series B
Last raised
- May 2019
Total raised
- $36M
Investors
- 10
About Modalis Therapeutics Corporation
Founded in 2016 by Haru Morita, Modalis Therapeutics Corporation operates from Tokyo, Japan. The company specializes in developing gene therapies and has executed six deals to date, with its most recent deal occurring on June 26, 2020.7 million shares at JPY 1200 per share on the Tokyo Stock Exchange Mother Sections.Modalis Therapeutics Corporation specializes in gene therapy and genome editing technologies aimed at treating genetic disorders. The company's core product offerings include MDL-207, a treatment for Dravet Syndrome, and MDL-101, which targets muscle dystrophies through epigenome editing. These therapies utilize advanced technologies such as CRISPR for precise gene modification and epigenome editing to control gene expression without altering the DNA sequence, providing effective solutions for conditions that currently lack comprehensive treatments.Looking ahead, Modalis Therapeutics plans to expand its product lineup and enter new markets. This includes targeted efforts to launch additional products focused on genetic disorders by 2024 and expanding its reach into new geographic regions in Asia and Europe, aligning with its strategic vision for growth.
Who invested in Modalis Therapeutics Corporation
10 investors across 4 rounds
See all investors in Modalis Therapeutics Corporation
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Modalis Therapeutics Corporation
Who invested in Modalis Therapeutics Corporation?
Modalis Therapeutics Corporation has 10 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Modalis Therapeutics Corporation raised?
Modalis Therapeutics Corporation has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Modalis Therapeutics Corporation last raise money?
Modalis Therapeutics Corporation's most recent round on record is a Series B, in May 2019.
What does Modalis Therapeutics Corporation do?
Founded in 2016 by Haru Morita, Modalis Therapeutics Corporation operates from Tokyo, Japan.
Where is Modalis Therapeutics Corporation headquartered?
Modalis Therapeutics Corporation is headquartered in Tokyo, Japan.
Which VCs invest in companies like Modalis Therapeutics Corporation?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at Modalis Therapeutics Corporation's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Modalis Therapeutics Corporation? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.